bioMérieux and the Food and Drug Administration Launch Research Collaboration to Improve Microbial Detection Tools to Combat Food-Borne Pathogens
CHICAGO, Feb. 28, 2024 /PRNewswire/ -- bioMérieux, a world leader in in vitro diagnostics for 60 years, has entered into a strategic research collaboration with the US Food and Drug Administration (FDA), Center for Food Safety and Applied Nutrition (CFSAN), Offices of Applied Research and Safety Assessment (OARSA) and Regulatory Science (ORS) to develop tools to combat food-borne pathogens. The agreement will pave the way for many innovative projects to improve detection and microbial characterization systems for pathogens that pose a risk in foods.
- The agreement will pave the way for many innovative projects to improve detection and microbial characterization systems for pathogens that pose a risk in foods.
- bioMérieux and the US Food and Drug Administration to collaborate on strategic research to combat food-borne pathogens.
- "bioMérieux is incredibly proud to enter into strategic, collaborative research with the FDA.
- bioMérieux provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.